Pluristem Therapeutics Inc

NASDAQ:PSTI   3:59:40 PM EDT
3.52
-0.33 (-8.57%)
Products

Pluristem Enters Collaboration With Innovare R&D To Expand COVID-19 Program To Mexico

Published: 12/29/2020 12:08 GMT
Pluristem Therapeutics Inc (PSTI) - Pluristem Enters Collaboration With Pharmaceutical Company Innovare Research and Development to Expand Pluristem’s Ards Associated With Covid-19 Program to Mexico.
Pluristem Therapeutics - Innovare Will Open Clinical Sites and Enroll Patients for Proposed Clinical Study in Mexico.
Pluristem Therapeutics Inc - Innovare Will Fund Study in Mexico and Will Purchase Plx Cells for Study From Pluristem.
Pluristem -agreement Grants Innovare Exclusive Distribution Rights in Mexico to Supply Plx Cells for Treating Severe Covid-19 Cases Complicated by Ards.
Pluristem Therapeutics Inc - All Intellectual Property and Manufacturing Rights Remain With Pluristem.